These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20538897)

  • 1. The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer.
    Rosanò L; Spinella F; Bagnato A
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R395-404. PubMed ID: 20538897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of the endothelin axis in ovarian tumor progression.
    Bagnato A; Spinella F; Rosanò L
    Endocr Relat Cancer; 2005 Dec; 12(4):761-72. PubMed ID: 16322321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelin axis: a novel target for pharmacotherapy of female malignancies.
    Smollich M; Wülfing P
    Curr Vasc Pharmacol; 2007 Jul; 5(3):239-48. PubMed ID: 17627567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
    Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
    Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM
    Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
    Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
    Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor.
    Maffei R; Bulgarelli J; Fiorcari S; Martinelli S; Castelli I; Valenti V; Rossi D; Bonacorsi G; Zucchini P; Potenza L; Vallisa D; Gattei V; Del Poeta G; Forconi F; Gaidano G; Narni F; Luppi M; Marasca R
    PLoS One; 2014; 9(6):e98818. PubMed ID: 24901342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy.
    Bagnato A; Spinella F; Rosanò L
    Can J Physiol Pharmacol; 2008 Aug; 86(8):473-84. PubMed ID: 18758494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor.
    Spinella F; Rosanò L; Elia G; Di Castro V; Natali PG; Bagnato A
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S140-3. PubMed ID: 15838264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity.
    Rosanò L; Di Castro V; Spinella F; Tortora G; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Jul; 67(13):6351-9. PubMed ID: 17616694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 acts as a survival factor in ovarian carcinoma cells.
    Del Bufalo D; Di Castro V; Biroccio A; Salani D; Rosanò L; Spinella F; Bagnato A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():302S-305S. PubMed ID: 12193109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
    Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
    Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo.
    Rosanò L; Di Castro V; Spinella F; Nicotra MR; Natali PG; Bagnato A
    Mol Cancer Ther; 2007 Jul; 6(7):2003-11. PubMed ID: 17620430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endothelin axis in cancer.
    Bagnato A; Rosanò L
    Int J Biochem Cell Biol; 2008; 40(8):1443-51. PubMed ID: 18325824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.